October 16, 2018 (1:30 PM)
Treatment options in high risk multiple myeloma
Paolo Corradini
Dip. Oncologia Medica ed Ematologia,
Fondazione IRCCS Istituto Nazionale dei Tumori, Milan
Nerviano Medical Sciences S.r.l.
Viale Luigi Pasteur 10
20014 Nerviano (MI)
Italy
Share Capital: € 1,200,000.00
fully paid-in
Company subject to the management and coordination of NMS Group S.p.A.